Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on June 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

FDA-RFQ- BioProfile FLEX2 Parts and Components-Brand Name or Equal

Closed
CDER-2026-133117Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334516
New
SLED
SP Labs Automated Biological Oxygen Demand Analyzer
Solicitation # 27-532EPA-LAB53-B-54370
The Illinois Environmental Protection Agency Laboratory is soliciting a small purchase contract for an automated Biological Oxygen Demand (BOD) analyzer to perform BOD and Carbonaceous Biochemical Oxygen Demand (CBOD) analysis in compliance with Standard Method 5210B. The required system must be fully automated, including sample preparation, pH adjustment, dissolved oxygen reading, and the addition of dilution water, chemicals, seeds, or inhibitors. Technical specifications require a minimum capacity of 54 sample bottles of 300 mL each and the ability to pull rinse water from a pressurized line or container. The analyzer must be delivered and fully functional at the Springfield, Illinois laboratory within 60 days of contract execution, with on-site training for at least two analysts provided within four weeks of installation. To be considered responsive, bidders must provide pricing for both the analyzer and a mandatory three-year service contract that includes repair parts, labor, and one annual preventive maintenance visit. The equipment must also include a one-year warranty. The awarded vendor is required to maintain significant insurance coverage, including 1 million dollars per occurrence for general commercial and auto liability, and 2 million dollars in annual aggregate general liability. Payment will be processed upon completion in accordance with the State Prompt Payment Act, and the contract is subject to the availability of funds, which may include federal funding. Submission requirements include financial disclosures, standard Illinois certifications, and pricing via the BidBuy portal.
FISCPROC532 - Fiscal / Procurement

POSTED

about 3 hours ago

DEADLINE

in 6 days
NAICS: 334516
New
Federal
Optical Modulator (No Substitutions)
Solicitation # AB484554
Brookhaven Science Associates (BSA), acting for Brookhaven National Laboratory under a prime contract with the Department of Energy, is soliciting quotations for one 65GHz packaged TFLN intensity modulator (C-band, Low Vpi version, Cryo-compatible), part number TFLN-G2-IM-1550-65-V-LV. This is a firm fixed price procurement where the award will be based on the lowest total evaluated responsive and responsible offeror. Quotations must include the country of origin, Unique Entity Identifier (UEI), and a published price list if available. Pricing must remain valid for at least sixty days from the quotation due date, and all costs, including freight, must be incorporated into the item price as separate line items for additional charges will not be included in the resulting purchase order. The procurement is subject to various Federal Acquisition Regulation (FAR) clauses and BNL-specific quality assurance requirements, including BNL-QA-101 and ISO 9001 standards. Deliveries must be made to Brookhaven National Laboratory in Upton, New York, and must comply with ASTM Standard D 3951 for commercial packaging. Specific restrictions include a prohibition on the use of vermiculite unless required by regulation, in which case asbestos-free certification is required. Invoices should be submitted electronically in PDF format to the BNL Fiscal Division and must clearly reference PO# 484554, with final invoices explicitly marked as Final. Any measuring and test equipment used must be traceable to NIST or another recognized national standard.
Brookhaven National Labor -Doe Contractor

POSTED

about 3 hours ago

DEADLINE

in 14 days
NAICS: 334516
New
Federal
CSS - Upgrading PExA 2.1 to Vial-Based (PExA Cap)
Solicitation # 75N98027Q00044
The National Institutes of Health (NIH), Office of the Director, is seeking a Firm-Fixed-Price purchase order under solicitation 75N98027Q00044 to upgrade a Government-owned PExA 2.1 instrument to PExA Cap functionality. This upgrade, intended for the Laboratory for Chronic Airway Infections, converts the existing paper-based collection mechanism to a vial-based system to eliminate post-collection substrate processing and improve analyte detectability. The scope of work includes the factory-level installation, servicing, and calibration of the instrument, the provision of 100 disposable sample kits, and a minimum one-year warranty. The contractor is also responsible for the fully insured, round-trip door-to-door transport of the sensitive scientific equipment between the contractor's facility and the NIH site in Bethesda, Maryland, using a carrier experienced in handling medical instrumentation. This unrestricted acquisition is conducted under FAR Subpart 12.6 for commercial items and is not expected to exceed the simplified acquisition threshold. The Government will award the contract based on best value, where technical capability, past performance, and delivery schedule are collectively considered significantly more important than price. While PExA AB of Gothenburg, Sweden is the brand name reference, the solicitation allows for equal products provided they meet all salient functional and performance characteristics. Proposals must be submitted by November 12, 2026, and must include the offeror's UEI, TIN, business size certification, and the country of origin for all supplies.
National Institutes Of Health Olao

POSTED

about 3 hours ago

DEADLINE

in 14 days

AI Contract Overview

Show more

The Center for Drug Evaluation and Research (CDER) is seeking commercial parts and consumables for three Nova BioProfile Flex 2 instruments under a combined synopsis/solicitation issued as a full and open competition. The requirement is for brand name or equal components compatible with the specific serial-numbered instruments: T262230070C, T26817050C with its external sampling module T2761720PC, and T26A200050C. All supplied items must be new, unused, defect-free, and not sourced from the grey market or refurbished; they must also retain at least 75% to 80% of their original shelf life upon delivery. The parts must function without any modification to the instruments as configured in the FDA facility and are used for automated bioanalysis, measuring pH, dissolved gases, metabolites, osmolality, and cell density across three distinct operational settings: a microbioreactor system for 48 vessels, an automated sampling setup for 5L glass bioreactors, and a pilot biomanufacturing lab. Items requiring refrigeration or classified as flammable must be shipped and delivered following manufacturer guidelines and applicable DOT/IATA regulations, and all packaging and marking must comply with government standards, including the contract number and contractor name. The contract is a Firm Fixed-Price (FFP) Purchase Order with a period of performance of 12 consecutive months following award, with four phased delivery windows spanning approximately 300 days, and all deliveries are FOB destination. The award will be made on a Lowest Price Technically Acceptable (LPTA) basis, where technical acceptability is a pass/fail gate determined by full compliance with all salient characteristics and requirements. Failure to meet any one requirement disqualifies the quote. Offerors must be the manufacturer or an authorized reseller, provide SAM.gov registration verification, include their Unique Entity ID and current address, and complete required representations and certifications either via SAM.gov or manually. Submissions must be emailed by 12:00 p.m. Eastern Time on June 26, 2026, using a specified subject line and formatted as Microsoft Word or Excel files without macros, passwords, or executables. Invoices must be submitted electronically through the Invoice Processing Platform (IPP), include an invoice log addendum with payment tracking details, and comply with FAR 32.905(b). The contract incorporates

General Info

Supply new, compatible parts for three Nova BioProfile FLEX 2 instruments; delivery by June 26, 2026.

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Place of Performance

Silver Spring, MD, USA

Set-Aside

NONE

Documents

2

FDA RFQ CDER-2026-133117 BioProfile Flex 2 Parts and Components

PDF, High priority: read this firstrfq
High

SOW-CDER-2026-133117 BioProfile Flex 2 Consumables

PDF, High priority: read this firstsow
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Office AddressRockville, MD, 20852, USA
Contacts
Brandon Rafus

Full Description

Show more

Request for Quotation:  FDA-RFQ-CDER-2026-133117 BioProfile FLEX2 Parts and Components-Brand Name or Equal



Notice of Combined Synopsis/Solicitation – This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with part 12. This announcement constitutes the only solicitation; quotes are being requested, and a separate written solicitation will not be issued.


Background – The Center for Drug Evaluation and Research (CDER) requires operational parts and consumables for three (3) currently owned Nova BioProfile Flex 2 instruments. To meet the purpose and objective of this requirement, a single Contractor shall provide the parts and components listed in the Statement of Work (SOW) that must be compatible with the corresponding three (3) NOVA BioProfile Flex 2 instruments:



Main FLEX2 instrument 1: Serial Number- T262230070C


Main FLEX2 instrument 2: Serial Number- T26817050C


External sampling module for instrument 2: T2761720PC


Main FLEX2 instrument 3: Serial Number- T26A200050C
 


Please note Main FLEX2 instrument 2 has two serial numbers because it has an additional module added which has its own Serial Number. The offeror is also expected to adhere to the:


the established delivery times as expressed in Section 5.1 of the attached combined solicitation/synopsis the fullest extent practicable.

Minimum Salient Characteristic  Requirements:


1. Compatibility is needed for three currently owned Nova BioProfile Flex 2 instruments as described in this Section (Section 5). The Contractor shall identify the following salient characteristics for BioProfile Flex-2 commercial parts and consumables or equal



2. Instrument identity: Manufacturer (Nova Biomedical), instrument name and model (BioProfile FLEX 2), and all three serial numbers of the government-owned instruments

3. Instrument function: Automated bioanalysis system for cell culture monitoring, measuring parameters such as pH, dissolved gases, metabolites, osmolality, and cell density
 


4. Compatibility requirement: All parts and consumables supplied must be fully compatible with and functional in the Nova BioProfile FLEX 2 as configured at the FDA facility, without modification to the instrument



5. Quality standard: All items must be new, unused, and free from defects; grey market and refurbished products are unacceptable



6. Shelf life: All items must arrive with at least 75% to 80% of their total shelf life remaining upon delivery



7. Cold chain: Items requiring refrigeration or classified as flammable must be shipped and delivered in accordance with manufacturer specifications and applicable DOT/IATA regulations



8. Authorization: Offeror must be the manufacturer or an authorized reseller of the items quoted
 


Place of Performance:


Food and Drug Administration


Attn: Erica Berilla


10903 New Hampshire Ave


Bldg. 52/72 RM 2232


Silver Spring, MD 20903



Period of Performance:


12 consecutive months commencing upon date of Award.



Please see the attached Statement of Work and Corresponding Justification for reference/utilization. Quotes are due by email on or before June 26, 2025, by 12:00 P.M. (Eastern Daylight Time) and should be sent to contact@example.gov.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541611
New
Federal
Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ
Solicitation # 75F40126R00009
Solicitation 75F40126R00009 is a request for proposals for a single Indefinite Delivery, Indefinite Quantity (IDIQ) contract to provide Contractor-Hosted Fully Integrated Records Facility (FIRF) services for the FDA. This acquisition is exclusively set aside for Service-Disabled Veteran-Owned Small Business (SDVOSB) concerns under NAICS code 541611. The contract has a maximum ceiling of 50 million dollars with a guaranteed minimum of 10,000 dollars. The anticipated period of performance consists of five 12-month ordering periods from December 1, 2026, through November 30, 2031, with an additional six-month option to extend services through May 31, 2032. The contract will support various task order types, including Time-and-Materials, Labor-Hour, and Firm-Fixed Price. The scope of work requires the contractor to manage an offsite document control facility to standardize records management and transition the agency toward a near 100 percent electronic environment for premarket and postmarket submissions. Key task areas include program management, document processing, scanning, data entry, tracking, temporary storage, and transition activities. Performance will primarily occur at FDA facilities in the Washington, D.C. metropolitan area, specifically within Maryland. Award will be made on a Lowest Price-Technically Acceptable (LPTA) basis, evaluating technical factors and past performance on an acceptable or unacceptable basis. Proposals must be submitted electronically in three separate volumes, with a final submission deadline of November 5, 2026, at 2:00 PM Eastern Time.
Administrative Management and General Management Consulting Services

POSTED

2 days ago

DEADLINE

in 7 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS